NRX Pharmaceuticals Inc
(NAS:NRXP)
$
2.08
0.04 (1.96%)
Market Cap: 22.66 Mil
Enterprise Value: 28.41 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 34/100 NRX Pharmaceuticals Inc (NRXP) Transcripts
- Q2 2024 NRX Pharmaceuticals Inc Earnings Call TranscriptAug 14, 2024$1.86 (-2.11%)Earnings
- Q1 2024 NRX Pharmaceuticals Inc Earnings Call TranscriptMay 14, 2024$3.18 (+6.35%)Earnings
- Q4 2023 NRX Pharmaceuticals Inc Earnings Call TranscriptApr 01, 2024$5.25 (+11.25%)Earnings
- NRX Pharmaceuticals Inc Annual Shareholders Meeting TranscriptDec 19, 2023
- Q3 2023 NRX Pharmaceuticals Inc Earnings Call TranscriptNov 14, 2023$3.5 (+4.32%)Earnings
- Q2 2023 NRX Pharmaceuticals Inc Earnings Call TranscriptAug 14, 2023$3.31 (+0.33%)Earnings
- NRX Pharmaceuticals Inc at H.C. Wainwright Neuropsychiatry Virtual Conference TranscriptJun 26, 2023
- NRX Pharmaceuticals Inc Corporate and Strategic Update Conference Call TranscriptJun 05, 2023
- Q1 2023 NRX Pharmaceuticals Inc Earnings Call TranscriptMay 16, 2023$6.46 (-7.26%)Earnings
- Q4 2022 NRX Pharmaceuticals Inc Earnings Call TranscriptMar 30, 2023$7.37 (-1.72%)Earnings
- Q3 2022 NRX Pharmaceuticals Inc Earnings Call TranscriptNov 14, 2022$9 (-9.99%)Earnings
- NRX Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 14, 2022
- Q2 2022 NRX Pharmaceuticals Inc Earnings Call TranscriptAug 15, 2022$7.49 (-6.29%)Earnings
- Q2 2021 NRX Pharmaceuticals Inc Earnings Call TranscriptAug 17, 2021$124.7 (-12.49%)Earnings
- 1